Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight or Obese, Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07775404
What this trial is testing

Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

Who this might be right for
ObesityOverweight
AstraZeneca 351
Large-scale testing (Phase 3)Study completedNCT05872620
What this trial is testing

Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Who this might be right for
ObesityOverweightType 2 Diabetes
Eli Lilly and Company 1,613
Early research (Phase 1)Study completedNCT06435676
What this trial is testing

Single and Multiple Doses HRS9531 Tablets in Healthy Subjects

Who this might be right for
Overweight or Obesity; Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 72
Not applicableUnknownNCT03058029
What this trial is testing

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

Who this might be right for
OverweightDiabetesPreDiabetes+1 more
Gelesis, Inc. 300
Post-approval studies (Phase 4)Active Not RecruitingNCT07438444
What this trial is testing

Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

Who this might be right for
Diabetes Mellitus, Type 2ObesityOverweight
Eli Lilly and Company 344
Testing effectiveness (Phase 2)Active Not RecruitingNCT06603571
What this trial is testing

Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Who this might be right for
ObesityOverweight
Eli Lilly and Company 367
Testing effectiveness (Phase 2)Active Not RecruitingNCT06643728
What this trial is testing

Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 252
Post-approval studies (Phase 4)Study completedNCT00928005
What this trial is testing

Evaluating the Effects of a Diet and Exercise Program in People With Type 2 Diabetes or Prediabetes: (The SHAPE3 Study)

Who this might be right for
OverweightObesityType 2 Diabetes+1 more
Johns Hopkins University 77
Early research (Phase 1)Study completedNCT07004322
What this trial is testing

A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Novo Nordisk A/S 20
Not applicableLooking for participantsNCT06694012
What this trial is testing

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Type 2 DiabetesDiabetes Mellitus+16 more
Osaka Metropolitan University 2,000
Not applicableStudy completedNCT01295229
What this trial is testing

Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Obesity
University of Washington 43
Large-scale testing (Phase 3)Active Not RecruitingNCT06993792
What this trial is testing

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

Who this might be right for
ObesityOverweightType 2 Diabetes
Eli Lilly and Company 1,400